NEW DELHI, (PNA/PTI) — Emphasising that pricing aspects of pharmaceuticals are critical for the general public, CCI Chairman Ashok Chawla has said that some cases of probe into alleged unfair practices in this space are in the “pipeline”.
Competition Commission of India has already slapped penalties on some entities, including chemists and druggists associations, for indulging in unfair trade practices.
“There are a number of cases, which have been dealt with.